Study Design: Experimental human study. Purpose: To determine whether angiopoietin-like protein 2 (ANGPTL2) is highly expressed in the hyperplastic facet joint (FJ) synovium and whether it activates interleukin-6 (IL-6) secretion in FJ synoviocytes. Overview of Literature: Mechanical stress-induced synovitis is partially, but significantly, responsible for degenerative and subsequently osteoarthritic changes in the FJ tissues in patients with lumbar spinal stenosis (LSS). However, the underlying molecular mechanism remains unclear. IL-6 is highly expressed in degenerative FJ synovial tissue and is responsible for local chronic inflammation. ANGPTL2, an inflammatory and mechanically induced mediator, promotes the expression of IL-6 in many cells. Methods: FJ tissues were harvested from five patients who had undergone lumbar surgery. Immunohistochemistry for ANGPTL2, IL-6, and cell markers was performed in the FJ tissue samples. After cultured synoviocytes from the FJ tissues were subjected to mechanical stress, ANGPTL2 expression and secretion were measured quantitatively using real-time quantitative reverse-transcription-polymerase chain reaction and enzyme-linked immunosorbent assay (ELISA), respectively. Following ANGPTL2 administration in the FJ synoviocytes, anti-nuclear factor-κB (NF-κB) activation was investigated using immunocytochemistry, and IL-6 expression and secretion were assayed quantitatively with or without NF-κB inhibitor. Moreover, we assessed whether ANGPTL2-induced IL-6 modulates leucocyte recruitment in the degenerative process by focusing on the monocyte chemoattractant protein-1 (MCP-1) expression. Results: ANGPTL2 and IL-6 were highly expressed in the hyperplastic FJ synovium samples. ANGPTL2 was co-expressed in both, fibroblast-like and macrophage-like synoviocytes. Further, the expression and secretion of ANGPTL2 in the FJ synoviocytes increased in response to stimulation by mechanical stretching. ANGPTL2 protein promoted the nuclear translocation of NF-κB and induced IL-6 expression and secretion in the FJ synoviocytes. This effect was reversed following treatment with NF-κB inhibitor. Furthermore, ANGPTL2-induced IL-6 upregulated the MCP-1 expression in the FJ synoviocytes. Conclusions: Mechanical stress-induced ANGPTL2 promotes chronic inflammation in the FJ synovium by activating IL-6 secretion, leading to FJ degeneration and subsequent LSS.
Introduction
Lumbar spinal stenosis (LSS) includes intervertebral disc (IVD) degeneration, facet joint osteoarthritis (FJ-OA), and ligamentum flavum hypertrophy (LFH) [1] . IVD degeneration is the primary event, and the biomechanical insufficiency induced via this change causes a transfer of backward stresses to the facet joints (FJs), resulting in degenerative changes in the FJ, further lumbar instability, and LFH formation [2] [3] [4] . The morphological changes that accompany FJ-OA, including bony proliferation and apophyseal malalignment, assist in narrowing the lumbar spinal canal and intervertebral foramen, causing low back pain, leg pain, and intermittent claudication via direct nerve compression [4] .
The etiology of osteoarthritis (OA) is multifactorial and includes systemic and local biomechanical factors [5] . Mechanical compression is one of the factors responsible for the degeneration of the appendicular joints, such as the knee. Subsequently, synovitis occurs locally in the joints, similar to rheumatoid arthritis (RA) [5, 6] . The overexpression of inflammatory mediators activates the progression of cartilage degeneration in the joints [7] [8] [9] . Some trials have shown that FJ degeneration leading to OA changes may be partly attributable to the chronic inflammation observed in FJ tissues and in limb joints [10] [11] [12] . Interleukin-6 (IL-6) is considered a key factor in chronic inflammation and tissue remodeling [13] , and high concentrations of IL-6 can be detected in the synovium of LSS-FJ tissues [10, 11] . Several studies have investigated the biomechanisms underlying FJ inflammation; however, the mechanism of IL-6 upregulation remains unclear.
Angiopoietin-like protein 2 (ANGPTL2), an inflammatory mediator, accelerates the progression of various noninfectious inflammatory processes that are associated with RA [14] , abdominal aortic aneurysms [15] , obesityassociated metabolic abnormalities [16] , and LFH [17, 18] . ANGPTL2 secretion is promoted by various pathological conditions, such as hypoxia, malnutrition, endoplasmic reticulum stress [16] , and mechanical stress [17] . ANG-PTL2 regulates the expression of some inflammatory cytokines, including IL-6 [16, 18] . We hypothesized that ANGPTL2 is expressed at high levels in the degenerative FJ tissues of LSS patients and that mechanical stressinduced ANGPTL2 accelerates FJ inflammation via the activation of IL-6 expression. Based on this hypothesis, the present study aimed to investigate whether ANGPTL2 contributes to the pathogenesis of FJ inflammation using the FJ synovium and synovial cells harvested from LSS patients.
Materials and Methods

Patients and ethics
The FJ synovium samples (n=5) used in this study were provided by patients whose FJs were diagnosed as hyperplastic and hydrarthrotic during preoperative imaging examinations. The study population comprised two men and three women (age, 54-73 years; mean age, 65.6 years) who underwent lumbar surgery at the L4/5 level for LSS at Kumamoto University Hospital between September 2015 and March 2016. The study was approved by the Kumamoto University Ethics Committee (no., 1303), and written informed consent was obtained from all the patients. The trial complied with the principles in the Declaration of Helsinki in 1975.
Immunohistochemistry
FJ synovium samples were fixed in 4% paraformaldehyde (PFA), embedded in paraffin, and sliced into 4-µm-thick sections. After pretreatment of the sections with Target Retrieval Solution (pH 9; Dako, Glostrup, Denmark), endogenous peroxidases were blocked using 3% hydrogen peroxide in methanol for 20 minutes. The following primary antibodies were used: anti-human ANGPTL2 (rabbit polyclonal, 1:100, 12316-1-AP; Proteintech, Chicago, IL, USA), anti-vimentin (mouse monoclonal, 1:100, ab8069; Abcam, Cambridge, MA, USA), anti-CD68 (mouse monoclonal, 1:100, ab31630; Abcam), anti-CD15 (mouse monoclonal, 1:50, ab188610; Abcam), anti-CD45 (rabbit polyclonal, 1:100, ab10558; Abcam), anti-IL-6 (rabbit polyclonal, 1:400, ab6672; Abcam), and anti-monocyte chemoattractant protein-1 (MCP-1, rabbit polyclonal, 1:100, ab9669; Abcam). Following treatment with a peroxidase-labeled secondary antibody (Histofine Simple Stain Max PO; Nichirei, Tokyo, Japan), immunoreactivity was visualized using histofine 3,3'-diaminobenzine (Dojindo Molecular Technologies, Kumamoto, Japan). The sections were counterstained with hematoxylin and analyzed using an Olympus BX51 light microscope (Olympus, Tokyo, Japan). For double immunofluorescence staining, anti-ANGPTL2 (1:200), anti-vimentin (1:200), and anti-CD68
(1:200) were used as the primary antibodies, and Alexa Fluor 488-labeled anti-rabbit immunoglobulin G (IgG, 1:500, ab150077; Abcam) and Alexa Fluor 594-labeled anti-mouse IgG (1:500, ab150116; Abcam) were used as secondary antibodies. The nuclei were counterstained with 4' ,6'-diamidino-2-phenylindole (DAPI).
Isolation and culture of facet joint synoviocytes
FJ tissue samples that were harvested from LSS patients were washed in physiological saline, minced, and incubated for 1 hour at 37°C in Dulbecco's modified Eagle's medium (DMEM; Gibco Life Technologies, Carlsbad, CA, USA) that contained 0.2% type I collagenase (Gibco Life Technologies) and 1% penicillin-streptomycin (Gibco Life Technologies). The suspension was filtered using a 100-µm mesh cell strainer (Becton Dickinson and Co., Franklin Lakes, NJ, USA), and the cells were seeded into the wells of a 6-well plate (Becton Dickinson and Co.) containing DMEM with 10% fetal bovine serum (FBS, Gibco Life Technologies) and 1% penicillin-streptomycin. The subsequent experiments were conducted using cells from primary to the third passage.
Stimulation of facet joint synoviocytes via mechanical stretching
FJ synoviocytes were seeded into a silicone chamber (STB-CH-10; Strex Inc., Osaka, Japan) at a density of 1×10 5 cells/chamber. The chamber was attached to a stretching apparatus (STB-140, Strex Inc.), and a cyclic uniaxial stretch (10% elongation) was applied for 6 hours or 12 hours (10 cycles/min; 37°C, 5% CO 2 ) [17] . After stimulation via stretching, total RNA was isolated from the cells and reverse-transcribed for analyzing ANGPTL2 expression using polymerase chain reaction (PCR). The relative abundance of target transcripts was normalized to the expression of 18S ribosomal RNA (18S rRNA). The primers used for this analysis were as follows: ANGPTL2 forward (5'-GCCACCAAGTGTCAGCCTCA-3') and reverse (5'-TGGACAGTACCAAACATCCAACATC-3') and 18S rRNA forward (5'-TTTGCGAGTACTCAACAC-CAACATC-3') and reverse (5'-GAGCATATCTTCG-GCCCACAC-3'). For the analysis of ANGPTL2 protein, subconfluent FJ synoviocytes cultured in a silicone chamber (STB-CH-10) were washed with phosphate-buffered saline (PBS), and the medium was changed to serum-free DMEM. After 24 hours of stimulation (10% elongation, 10 cycles/min; 37°C, 5% CO 2 ), the medium was harvested. The secreted ANGPTL2 protein was measured using an ANGPTL2 enzyme-linked immunosorbent assay (ELISA) kit (IBL, Fujioka, Japan) as per the manufacturer's instructions.
Stimulation of facet joint synoviocytes with angiopoietin-like protein 2
For immunofluorescent staining, FJ synoviocytes were seeded onto a 4-well culture slide (Becton Dickinson and Co.), cultured subconfluently, treated with recombinant ANGPTL2 protein (5 µg/mL), and incubated for 1 hour (37°C, 5% CO 2 ). The cells were then fixed with 4% PFA and treated with anti-nuclear factor-κB (NF-κB) p65 antibody (rabbit polyclonal, 1:100, sc-372; Santa Cruz Biotechnology, Santa Cruz, CA, USA). Alexa Fluor 488-labeled anti-rabbit IgG (1:500, ab150077; Abcam) was applied as the secondary antibody, and DAPI was used for nuclear staining. ANGPTL2 protein (5 µg/mL) was added to the wells of a 12-well plate (Becton Dickinson and Co.) containing subconfluent FJ synoviocytes with or without the NF-κB inhibitor BAY 11-7082 (10 µM; Wako Pure Chemical Industries, Osaka, Japan). DMEM, containing 10% FBS and 1% penicillin-streptomycin, was added to each well, and the cells were incubated for 6 hours before RNA extraction. The IL6 mRNA expression was evaluated using realtime quantitative reverse-transcription (qRT)-PCR. The relative abundance of target transcripts was normalized to the expression of 18S rRNA. The IL6 primers were as follows: forward, (5'-AAGCCAGAGCTGTGCAGAT-GAGTA-3') and reverse, (5'-TGTCCTGCAGCCACTG-GTTC-3'). In order to analyze the IL-6 protein expression after ANGPTL2 administration, subconfluent FJ synoviocytes cultured in a 6-well plate were washed with PBS, and the medium was changed to serum-free DMEM. ANGPTL2 (5 µg/mL) was added to each well, plates were incubated for 24 hours (37°C, 5% CO 2 ), and the amount of secreted IL-6 protein was measured using IL-6 ELISA kit (R&D Systems, Minneapolis, MN, USA).
Evaluation of monocyte chemoattractant protein-1 expression
To evaluate the MCP-1 response to inflammatory stimuli, recombinant IL-6 protein (200 ng/mL; Wako Pure Chemical Industries, Osaka, Japan) with the same amount of soluble IL-6 receptor α (sIL-6Rα; Wako Pure Chemical Industries) was first added to a 12-well plate (Becton Dickinson and Co.) to culture the synoviocytes. Thereafter, ANGPTL2 protein (5 µg/mL) was added to the same kind of plate (Becton Dickinson and Co.) containing subconfluent FJ synoviocytes with or without sIL-6Rα (200 ng/mL). Each plate was incubated for 6 hours before RNA extraction. MCP-1 mRNA expression was evaluated with qRT-PCR. The relative abundance of target transcripts was normalized to the expression of 18S rRNA. The MCP-1 primers were as follows: forward, (5'-CAAACTGAAGCTCGCACTCTCGCC-3') and reverse, (5'-CTCCTAATGTCACGCACGATTT-3').
Statistical analyses
Data are expressed as the mean±standard error of the mean values. Student t-tests were used for performing 
Results
Expression and cellular source of angiopoietin-like protein 2 in degenerative facet joint synovium
A large number of ANGPTL2-expressing cells were identified in the hyperplastic FJ tissues in all LSS patients (Fig.  1A) . Thereafter, the cell types present in the degenerative FJ tissues were examined with immunohistochemical analysis using antibodies against vimentin (a mesenchymal cell marker), CD68 (a macrophage marker), CD15 (a granulocyte marker), and CD45 (a lymphocyte marker). Patient cells expressed vimentin and CD68 at high levels, while the expression of CD15 and CD45 was very low, suggesting that hyperplastic FJ tissue mainly includes fibroblast-like synoviocytes and macrophagelike synoviocytes (Fig. 1B) . Immunofluorescent double staining with anti-ANGPTL2 and anti-vimentin or anti-CD68 antibodies showed that ANGPTL2 was partially expressed by vimentin-positive cells and CD68-positive cells. This suggests that ANGPTL2 is produced by both fibroblast-like and macrophage-like synoviocytes in the FJ tissues (Fig. 1C ). IL-6 was also expressed in the cells of the hyperplastic FJ tissues (Fig. 1D) , suggesting that IL-6 and ANGPTL2 are highly expressed in the degenerative FJ synovium.
Upregulation of angiopoietin-like protein 2 by mechanical stretching stimulation
In order to determine whether mechanical stress directly induces ANGPTL2 expression, we subjected FJ synoviocytes isolated from LSS patients to repeated cyclic mechanical stretching, as described above. Stretching stimulation increased ANGPTL2 mRNA expression in the FJ synoviocytes and ANGPTL2 protein secretion in the culture medium ( Fig. 2A, B) . These findings suggest that ANGPTL2 production via mechanical stress could contribute to the pathological process underlying FJ degeneration.
Induction of interleukin-6 by angiopoietin-like protein 2 in facet joint synoviocytes
ANGPTL2 promotes the nuclear translocation of NF-κB and the subsequent induction of IL-6 [16, 18] ; therefore, we investigated whether ANGPTL2 activates the nuclear translocation of NF-κB and induces IL6 expression in FJ synoviocytes. We confirmed that NF-κB nuclear translocation in FJ synoviocytes was induced by ANGPTL2 treatment (Fig. 3) . Further, ANGPTL2 upregulated the IL6 mRNA expression and IL-6 protein secretion in FJ synoviocytes. In contrast, NF-κB inhibition via treatment with BAY11-7085 abrogated the elevation of IL-6 at the mRNA and protein levels (Fig. 4A, B ). These results demonstrate that ANGPTL2 induces IL-6 expression and secretion via the nuclear translocation of NF-κB in FJ synoviocytes.
Induction of chronic inflammation by angiopoietinlike protein 2 in facet joint tissues
As the combination of IL-6 with sIL-6Rα increases the MCP-1 secretion of the stromal cells, favoring a transition from neutrophil to monocyte/macrophage accumulation and formulating chronic inflammation at the site of injury [13] , we attempted to determine whether MCP-1 expresses in the LSS-FJ tissues and whether ANGPTL2-induced IL-6 upregulates the MCP-1 expression in FJ synovio- cytes. As expected, several MCP-1-expressing cells were detected in the hyperplastic FJ tissues (Fig. 5A) , and the expression of MCP-1 in FJ synoviocytes was elevated due to IL-6/sIL-6Rα administration (Fig. 5B) . Only Angptl2 protein with sIL-6Rα increased the MCP-1 mRNA expression (Fig. 5C ). These findings suggest that ANGPTL2-induced IL-6 combined with sIL-6Rα can raise the MCP-1 secretion, leading to macrophage recruitment in FJ synovium and subsequent chronic inflammation.
Discussion
In this study, we showed that ANGPTL2 is abundantly expressed in the hyperplastic FJ tissues of LSS patients and that mechanical stress-induced ANGPTL2 upregulated the expression and secretion of IL-6 in the FJ synoviocytes via NF-κB activation and increased MCP-1 expression associated with chronic inflammation. We demonstrated that ANGPTL2 could be a key factor in promoting FJ inflammation by activating IL-6 expression.
FJs have the same anatomy as the appendicular joints; they are covered by the hyaline cartilage and are enclosed by the synovium and capsule [2] . Similar to that in RA, local inflammatory reactions occur in the OA joints and many chemical factors derived from the synoviocytes participate in cartilage destruction [5] [6] [7] [8] [9] . An in vitro study reported that synoviocytes are potent sources of IL-6 that contributes to inflammatory arthropathies [20] . In clinical practice, IL-6 represents a significant biomarker of OA because the circulatory and intra-articular levels of IL-6 are increased in patients with OA of the knee. In particular, patients in the early stage of OA exhibit high serum IL-6 levels [21, 22] . Some researchers have suggested that, similar to that in the limb joints, the first stage of OA changes in the FJs may result from repetitive mechanical stress, which subsequently induces FJ synovitis. They found that inflammatory cytokines, such as IL-6 were expressed at higher concentrations in the synovial membranes of LSS patients than in those of lumbar disc herniation (LDH) patients without severe FJ degeneration [10, 11] .
ANGPTL2 is induced under various stress conditions, such as hypoxia, malnutrition, endoplasmic reticulum stress [16] , and mechanical stress [17] . In this study, the expression and secretion of ANGPTL2 from the synoviocytes of the hyperplastic FJ tissues were elevated in response to stretching stimulation. Therefore, the induction of ANGPTL2 by lumbar mechanical stress could partially trigger the first step of the FJ degenerative process. Based on the present results, we can conclude that ANGPTL2-induced IL-6 can lead to synovitis that progresses to FJ inflammation and the subsequent degenerative process.
IL-6 plays important roles in regulating the transition from neutrophil (acute inflammation) to monocyte (chronic inflammation) recruitment and is a part of tissue remodeling and degenerative pathogenesis [13] . Our study found that there were few neutrophils and several macrophage-like cells in the degenerative FJ tissue, and that ANGPTL2 protein with sIL-6Rα elevated the MCP-1 expression in the cultured synoviocytes. Thus, our FJ samples were in the chronic inflammatory phase and ANG-PTL2-induced IL-6 could recruit monocytes via MCP-1 and establish a chronic inflammatory condition. sIL-6Rα is derived from neutrophils in the acute inflammatory phase [13] ; therefore, we consider that the neutrophils in 
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the initial FJ inflammation might contribute to sIL-6Rα secretion and the serum receptor could induce MCP-1 in combination with IL-6 derived from the FJ synoviocytes, shifting to the FJ chronic inflammation. Further studies on FJ samples in the acute inflammatory phase are necessary to understand the mechanism. Inflammation and degenerative changes in the FJs have been implicated in chronic lower back pain in about 25% of the patients [23] . Radiculopathy is induced not only by the direct nerve-root compression of the FJ osteophytes, but also by the spread of chemical factors, such as IL-6 produced by the FJs [24] [25] [26] . Thus, our results indicate that radiculopathy and sciatica that are induced by chronic FJ inflammation, can also be treated by targeting ANG-PTL2.
There are certain limitations of this study. First, our tissue sample size was very small because it was difficult to harvest tissue samples large enough for the histological analysis. Second, control FJ synovium specimens were unavailable because minimally invasive surgery has been adopted for LDH treatment at our institution, and LDH-FJ tissues are too thin to harvest the samples without destroying the FJs and causing consequent iatrogenic lumbar instability. Therefore, a control group could not be employed, and the expression pattern of ANGPTL2 in normal FJ tissues was unclear. Further investigations using control samples are necessary for clarifying the degenerative mechanism.
Conclusions
Mechanical stress-induced ANGPTL2 produced by synoviocytes promotes FJ inflammation via the induction of IL-6 secretion, resulting in degenerative changes and subsequent FJ-OA. ANGPTL2 could be a key mediator of FJ inflammation and degeneration; therefore, anti-ANG-PTL2 treatment may be a novel strategy for preventing FJ-OA changes and subsequent LSS formation.
